Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Audit Trail Review for GMP Systems – V 2.0

Posted on By

API Manufacturing: SOP for Audit Trail Review for GMP Systems – V 2.0

Standard Operating Procedure for Audit Trail Review for GMP Systems in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/177/2025
Supersedes SOP/API/177/2022
Page No. Page 1 of 14
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To establish a standard procedure for the periodic review of audit trails from computerized systems used in Good Manufacturing Practice (GMP) regulated activities to ensure data integrity and compliance in API manufacturing.

2. Scope

This SOP is applicable to all GMP-relevant computerized systems (e.g., HPLC, GC, FTIR, balances, LIMS, EMS, BMS) that generate, record, or store GMP data

at the API manufacturing facility.

3. Responsibilities

  • QA Officer/Executive: Conducts audit trail reviews as per defined schedule, identifies irregularities, and reports findings.
  • QC/Production/System User: Ensures system audit trails are enabled and not deleted or overwritten.
  • System Administrator/IT: Provides access to audit trail data, supports report generation, ensures system backup and security.
  • QA Head: Reviews audit trail trend reports and ensures corrective action is taken in case of data integrity issues.
See also  API Manufacturing: SOP for Handling of Returned Drug Product - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring implementation and effectiveness of the audit trail review process across all GMP computerized systems.

5. Procedure

5.1 Definition and Regulatory Requirement

  1. An audit trail is a secure, computer-generated, time-stamped electronic record that allows reconstruction of events relating to the creation, modification, or deletion of GMP data.
  2. As per 21 CFR Part 11, EU Annex 11, and MHRA GXP Data Integrity Guidelines, periodic audit trail review is mandatory for GMP systems.

5.2 Identification of GMP Systems Requiring Audit Trail Review

  1. QA shall maintain a Master List of GMP Systems (Annexure-1) that require audit trail review.
  2. This includes:
    • Analytical instruments (e.g., HPLC, GC, UV, FTIR)
    • Balance systems used for raw material weighing
    • Environmental and utility monitoring systems (e.g., BMS, EMS)
    • LIMS and electronic logbooks

5.3 Audit Trail Review Frequency

  1. Routine periodic review shall be conducted by QA:
    • Critical systems: Monthly (e.g., LIMS, HPLC)
    • Non-critical systems: Quarterly
  2. Review must also be conducted:
    • Before batch release
    • During deviation investigation
    • After system malfunction or failure

5.4 Review Process

  1. Access the audit trail via the system interface or export report with IT support.
  2. Review the following parameters:
    • User login/logout
    • Data creation/modification/deletion
    • Changes in method or results
    • Instrument time/date settings
    • Unauthorised access attempts
  3. Record review details in Audit Trail Review Log (Annexure-2).
See also  API Manufacturing: SOP for Labeling of Raw Materials with Status Tags - V 2.0

5.5 Handling Observations

  1. If any data integrity concern is observed (e.g., unauthorized changes, deleted data, unexplained overrides), raise an internal Observation Report (Annexure-3) and initiate a deviation.
  2. QA to conduct impact assessment and initiate CAPA where applicable.
  3. Notify regulatory authority in case of critical breach (as per site escalation policy).

5.6 Report and Trend

  1. QA shall prepare a Monthly Audit Trail Trend Report (Annexure-4) summarizing:
    • Total systems reviewed
    • Number and type of observations
    • Repeat violations
  2. Reports shall be reviewed by QA Head and discussed in the Quality Review Meeting.

5.7 Backup and Retention

  1. Audit trail data shall be backed up weekly and retained for a period of at least 5 years or as per regulatory requirement.
  2. Ensure data is stored in a secure location with limited access and audit capability.

6. Abbreviations

  • QA: Quality Assurance
  • IT: Information Technology
  • HPLC: High Performance Liquid Chromatography
  • GC: Gas Chromatography
  • LIMS: Laboratory Information Management System
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Master List of GMP Systems (Annexure-1)
  2. Audit Trail Review Log (Annexure-2)
  3. Audit Trail Observation Form (Annexure-3)
  4. Monthly Audit Trail Trend Report (Annexure-4)
See also  API Manufacturing: SOP for QC Lab Access and Control Procedure - V 2.0

8. References

  • 21 CFR Part 11 – Electronic Records and Signatures
  • EU GMP Annex 11 – Computerized Systems
  • MHRA GxP Data Integrity Guidelines
  • ICH Q9 – Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Master List of GMP Systems

System Name Location Review Frequency Criticality
HPLC-01 QC Lab Monthly High
Balance-05 Dispensing Room Quarterly Medium

Annexure-2: Audit Trail Review Log

Date System Name Reviewer Observations Remarks
01/04/2025 HPLC-01 Sunita Reddy None Compliant

Annexure-3: Audit Trail Observation Form

Observation No. Date System Description CAPA Initiated
ATR/2025/02 03/04/2025 GC-02 Deleted run without comment Yes

Annexure-4: Monthly Audit Trail Trend Report

Month Systems Reviewed Observations CAPAs Raised
March 2025 12 2 2

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Release New SOP QA Head
14/04/2025 2.0 Included audit trail frequency and annexures GxP Compliance Update QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: Zeta Potential Determination SOP – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Operation of Autoclaves for Sterilization – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version